Psyllid ID: psy11022
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 492 | ||||||
| 328701295 | 403 | PREDICTED: alpha-1A adrenergic receptor- | 0.678 | 0.828 | 0.607 | 1e-122 | |
| 189235262 | 3197 | PREDICTED: similar to AGAP005356-PA [Tri | 0.703 | 0.108 | 0.538 | 1e-114 | |
| 270004135 | 359 | hypothetical protein TcasGA2_TC003453 [T | 0.703 | 0.963 | 0.538 | 1e-107 | |
| 242020744 | 388 | G-protein coupled octopamine receptor, p | 0.715 | 0.907 | 0.526 | 1e-101 | |
| 340715965 | 376 | PREDICTED: neuropeptide Y receptor-like | 0.672 | 0.880 | 0.488 | 2e-89 | |
| 350419966 | 376 | PREDICTED: neuropeptide Y receptor-like | 0.664 | 0.869 | 0.489 | 3e-89 | |
| 383860183 | 359 | PREDICTED: neuropeptide Y receptor-like | 0.666 | 0.913 | 0.492 | 3e-87 | |
| 328776745 | 356 | PREDICTED: neuropeptide Y receptor-like | 0.668 | 0.924 | 0.473 | 1e-82 | |
| 345484578 | 395 | PREDICTED: alpha-1B adrenergic receptor- | 0.668 | 0.832 | 0.460 | 3e-81 | |
| 158294045 | 456 | AGAP005356-PA [Anopheles gambiae str. PE | 0.670 | 0.723 | 0.459 | 2e-77 |
| >gi|328701295|ref|XP_001946275.2| PREDICTED: alpha-1A adrenergic receptor-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 206/339 (60%), Positives = 259/339 (76%), Gaps = 5/339 (1%)
Query: 27 DTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALAD 86
D V P TL +W+RVARLLI GLSV+GS+GN YMISSVMIEDHL +RGNT++A ALAD
Sbjct: 31 DAVSPVTLSMEWSRVARLLIMIGLSVIGSIGNVYMISSVMIEDHLNKRGNTFVANVALAD 90
Query: 87 LLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLC 146
LL+SG+VIP SAV+IL+G++ + P+ C QWFL++LC LVTV T+A +A ENY+RLC
Sbjct: 91 LLISGLVIPASAVVILSGLQDSPPV----CQFQWFLSILCCLVTVLTMAAVAAENYIRLC 146
Query: 147 MPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKVGPDYCSKKVSYMELYQGIIGSLF 206
+ PECY + + I + IW++S +L TLQ +Y +GPDYC+KK+S + Q +
Sbjct: 147 LTPECYAKLTVTKITTLLFAIWIISSILVTLQSVYNMGPDYCNKKISRIVPTQALTAGAI 206
Query: 207 FFIPIIITCILYMKITYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCI 266
P++IT LYM+ITY+V +AR NPSFKPP+ F WDYSLML N YS++MF+V W PF I
Sbjct: 207 VLAPLLITAGLYMRITYQVHVARLNPSFKPPLAFNWDYSLMLANAYSFVMFVVFWAPFTI 266
Query: 267 VMSVASF-RHQITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTF 325
V+++A+ R Q FY LAWLALSKSC N+++YC NRHFRNAY+NLFHYCCCKTTVTF
Sbjct: 267 VLALATIQRQQSAQVFYNLAWLALSKSCFNNLVYCAGNRHFRNAYVNLFHYCCCKTTVTF 326
Query: 326 SRRSRGDATRPSGDVRVHIIPGYNMYSYTSPQRGRDASK 364
SRR+R ATRPSGDVRVHIIPGYNMYSYTSP R R++
Sbjct: 327 SRRARDGATRPSGDVRVHIIPGYNMYSYTSPTRSRESGS 365
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189235262|ref|XP_001814462.1| PREDICTED: similar to AGAP005356-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|270004135|gb|EFA00583.1| hypothetical protein TcasGA2_TC003453 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|242020744|ref|XP_002430811.1| G-protein coupled octopamine receptor, putative [Pediculus humanus corporis] gi|212516014|gb|EEB18073.1| G-protein coupled octopamine receptor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
| >gi|340715965|ref|XP_003396476.1| PREDICTED: neuropeptide Y receptor-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|350419966|ref|XP_003492355.1| PREDICTED: neuropeptide Y receptor-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|383860183|ref|XP_003705570.1| PREDICTED: neuropeptide Y receptor-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
| >gi|328776745|ref|XP_393375.4| PREDICTED: neuropeptide Y receptor-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
| >gi|345484578|ref|XP_003425076.1| PREDICTED: alpha-1B adrenergic receptor-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
| >gi|158294045|ref|XP_001688647.1| AGAP005356-PA [Anopheles gambiae str. PEST] gi|157015382|gb|EDO63653.1| AGAP005356-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 492 | ||||||
| ZFIN|ZDB-GENE-990415-154 | 347 | mtnr1al "melatonin receptor ty | 0.573 | 0.812 | 0.269 | 7.9e-19 | |
| UNIPROTKB|F1PK71 | 461 | ADRA1B "Alpha-1B adrenergic re | 0.461 | 0.492 | 0.255 | 2.4e-18 | |
| UNIPROTKB|J9PBA4 | 509 | ADRA1B "Alpha-1B adrenergic re | 0.461 | 0.445 | 0.255 | 3.6e-18 | |
| UNIPROTKB|P18841 | 515 | ADRA1B "Alpha-1B adrenergic re | 0.461 | 0.440 | 0.255 | 3.7e-18 | |
| UNIPROTKB|F1RR36 | 518 | ADRA1B "Uncharacterized protei | 0.461 | 0.438 | 0.255 | 3.8e-18 | |
| UNIPROTKB|P35368 | 520 | ADRA1B "Alpha-1B adrenergic re | 0.461 | 0.436 | 0.255 | 3.9e-18 | |
| RGD|2054 | 515 | Adra1b "adrenoceptor alpha 1B" | 0.414 | 0.396 | 0.254 | 2.8e-17 | |
| UNIPROTKB|F1NIZ5 | 376 | ADRA1B "Uncharacterized protei | 0.402 | 0.526 | 0.246 | 4.1e-17 | |
| RGD|2831 | 358 | Hrh2 "histamine receptor H 2" | 0.581 | 0.798 | 0.255 | 4.4e-17 | |
| UNIPROTKB|P25102 | 358 | Hrh2 "Histamine H2 receptor" [ | 0.581 | 0.798 | 0.255 | 4.4e-17 |
| ZFIN|ZDB-GENE-990415-154 mtnr1al "melatonin receptor type 1A like" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 244 (91.0 bits), Expect = 7.9e-19, P = 7.9e-19
Identities = 83/308 (26%), Positives = 145/308 (47%)
Query: 30 DPSTLPYDW--NRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADL 87
D L + W ++ +LITT V+ +GN +I SV LR+ GN ++ A+ADL
Sbjct: 47 DIKYLSFPWVVTLLSSVLITT--IVVDVLGNLLVIVSVFRNRKLRKAGNAFVVSLAIADL 104
Query: 88 LVSGVVIPVSAVMILAGIKQAEPIK-EIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLC 146
LV+ + P ++L I I +I C + FL L + +++ + IA+ Y +C
Sbjct: 105 LVA--IYPYP--LVLTAIFHDRWIAGDIHCQISGFLMGLSVIGSIFNITGIAINRYCYIC 160
Query: 147 MPPECYTFFSKSHIILSVIMIWLVSIL-LTTLQFIYKVGPD----YCSKKVSYMELYQGI 201
+ FS + + VI++W +++L + F+ + D C+ S LY +
Sbjct: 161 HSLKYDKLFSNKNTVCYVILVWALTVLAIVPNWFVESLQYDPRVFSCTFAQSVSSLYTIM 220
Query: 202 IGSLFFFIPIIITCILYMKITYKVRLARQN--PSFKPPVIFGWDYSLMLTNMYSYIMFIV 259
+ + F +PI I Y++I V R+ P +P I D+ LT +++F V
Sbjct: 221 VVVVHFIVPIGIVTYCYLRIWILVIQVRRRVKPDSRPK-IKPHDFRNFLTMFVVFVLFAV 279
Query: 260 LWIPFCIV-MSVASFRH--QITPSFYYLA--WLALSKSCINSVLYCISNRHFRNAY---- 310
W P + ++VA Q P + + A ++A SC+N V+Y + N +FR Y
Sbjct: 280 CWAPLNFIGLAVAIHPRLGQSIPEWLFTASYFMAYFNSCLNGVIYGVLNHNFRKEYKRIV 339
Query: 311 INLFHYCC 318
+ +F + C
Sbjct: 340 LAIFKFNC 347
|
|
| UNIPROTKB|F1PK71 ADRA1B "Alpha-1B adrenergic receptor" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|J9PBA4 ADRA1B "Alpha-1B adrenergic receptor" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P18841 ADRA1B "Alpha-1B adrenergic receptor" [Mesocricetus auratus (taxid:10036)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1RR36 ADRA1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P35368 ADRA1B "Alpha-1B adrenergic receptor" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| RGD|2054 Adra1b "adrenoceptor alpha 1B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NIZ5 ADRA1B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| RGD|2831 Hrh2 "histamine receptor H 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P25102 Hrh2 "Histamine H2 receptor" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 492 | |||
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 9e-18 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 3e-08 | |
| PHA02834 | 323 | PHA02834, PHA02834, chemokine receptor-like protei | 0.001 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 45/247 (18%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 70 HLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLV 129
LR N ++ A+ADLL + P + ++ G P + +C + FL ++
Sbjct: 8 KLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGDW---PFGDALCKLVGFLFVVNGYA 64
Query: 130 TVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIY-------K 182
++ L I+++ Y+ + P + + ++++W++++LL+ ++ +
Sbjct: 65 SILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTVEE 124
Query: 183 VGPDYCS---KKVSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKPPVI 239
C + S Y + L F +P+++ + Y I +R ++ + +
Sbjct: 125 GNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGASQARAK 184
Query: 240 FGWDYSLMLTNMYSYIM--FIVLWIPFCIVMSVASFRHQITPSFYYLA-----WLALSKS 292
M ++ F++ W+P+ IV+ + S A WLA S
Sbjct: 185 RSSSKERKAAKMLLVVVVVFVLCWLPYHIVLLLDSLCPLSIWRLLPTALLITLWLAYVNS 244
Query: 293 CINSVLY 299
C+N ++Y
Sbjct: 245 CLNPIIY 251
|
This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 492 | |||
| KOG4219|consensus | 423 | 100.0 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 100.0 | |
| KOG4220|consensus | 503 | 100.0 | ||
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 100.0 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 100.0 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 100.0 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.97 | |
| KOG2087|consensus | 363 | 99.9 | ||
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 99.9 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 99.83 | |
| KOG4219|consensus | 423 | 99.77 | ||
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 99.77 | |
| KOG4220|consensus | 503 | 99.71 | ||
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 99.69 | |
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 99.62 | |
| PF05296 | 303 | TAS2R: Mammalian taste receptor protein (TAS2R); I | 99.58 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 99.55 | |
| PF10321 | 313 | 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept | 99.54 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 99.54 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.52 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 99.51 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 99.44 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 99.42 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 99.19 | |
| KOG2087|consensus | 363 | 99.14 | ||
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 99.06 | |
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 98.86 | |
| PF10327 | 303 | 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept | 98.83 | |
| PF10292 | 324 | 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c | 98.77 | |
| PF10326 | 307 | 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept | 98.73 | |
| PF02101 | 405 | Ocular_alb: Ocular albinism type 1 protein; InterP | 98.72 | |
| KOG4193|consensus | 610 | 98.65 | ||
| PF10318 | 302 | 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept | 98.65 | |
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 98.62 | |
| PF02118 | 275 | Srg: Srg family chemoreceptor; InterPro: IPR000609 | 98.59 | |
| KOG4564|consensus | 473 | 98.42 | ||
| PF10319 | 310 | 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept | 98.37 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 98.36 | |
| PF10316 | 273 | 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep | 98.35 | |
| PF04789 | 305 | DUF621: Protein of unknown function (DUF621); Inte | 98.24 | |
| PF00002 | 242 | 7tm_2: 7 transmembrane receptor (Secretin family); | 98.07 | |
| PF03125 | 365 | Sre: C. elegans Sre G protein-coupled chemorecepto | 97.95 | |
| PF02117 | 328 | 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept | 97.93 | |
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 97.4 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 97.39 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 97.34 | |
| PF10322 | 307 | 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept | 97.11 | |
| PF01534 | 328 | Frizzled: Frizzled/Smoothened family membrane regi | 96.62 | |
| PF02076 | 283 | STE3: Pheromone A receptor; InterPro: IPR001499 G- | 96.25 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 95.74 | |
| PF03383 | 153 | Serpentine_r_xa: Caenorhabditis serpentine recepto | 95.58 | |
| PF03383 | 153 | Serpentine_r_xa: Caenorhabditis serpentine recepto | 94.95 | |
| PF11970 | 76 | Git3_C: G protein-coupled glucose receptor regulat | 94.9 | |
| PF06681 | 226 | DUF1182: Protein of unknown function (DUF1182); In | 94.64 | |
| PF02175 | 236 | 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept | 94.5 | |
| KOG4289|consensus | 2531 | 90.7 | ||
| PF10316 | 273 | 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep | 82.34 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 81.99 |
| >KOG4219|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=322.51 Aligned_cols=281 Identities=20% Similarity=0.382 Sum_probs=238.8
Q ss_pred CCCcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccccchhhHHHHHHHHHHHhhhchhcHHHHHHHhcCCCccccc
Q psy11022 33 TLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIK 112 (492)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr~~~~~~l~~Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~~ 112 (492)
...+.+...+.++++.++.+++++||+++++++..+|++|+.+|+|++|||+||++++++..++.......+ +|.+|
T Consensus 28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal~~---~W~~G 104 (423)
T KOG4219|consen 28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYALHQ---EWYFG 104 (423)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHHHh---ccccc
Confidence 345667788899999999999999999999999999999999999999999999999999999988877775 59999
Q ss_pred cccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHHhHhhHHHHHHHHHhhhhhhhcc---------
Q psy11022 113 EIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKV--------- 183 (492)
Q Consensus 113 ~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~--------- 183 (492)
.+.|++..|+......+|++++++||+|||.||.||++.+ .++|.++..++++|+.++++++|..++..
T Consensus 105 ~f~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl~~r--~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~ 182 (423)
T KOG4219|consen 105 SFYCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPLQPR--PSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDG 182 (423)
T ss_pred cceeeeccccchhhhhHhHHHHHHHHHHHHHHHhhhcccC--CCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCC
Confidence 9999999999999999999999999999999999997654 89999999999999999999999877421
Q ss_pred -cccccccccccc-----------hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCCCC--CcccchhhHHHHH
Q psy11022 184 -GPDYCSKKVSYM-----------ELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQNPSFKP--PVIFGWDYSLMLT 249 (492)
Q Consensus 184 -~~~~C~~~~~~~-----------~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~~~~~~~~--~~~~~~~~~~~~~ 249 (492)
....|...++.. ..|.....++.+++|++++...|.+|.+++++.+..+.+.. .++.+.++|+.|+
T Consensus 183 ~~~~~~~~~~pe~~~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~~d~~~~~~kak~K~vkm 262 (423)
T KOG4219|consen 183 ESRVVCVTAWPEHVCPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQQDRKHEQLKAKKKVVKM 262 (423)
T ss_pred cceEEEEEecccccCCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccchhchhhHHHHHHHHHHHH
Confidence 122344443221 22666677899999999999999999999998764333222 3445668899999
Q ss_pred HHHHHHHHHHHhHhHHHHHHHHhccCC------cchHHHHHHHHHhhcccccchhhhhcChHHHHHHHHHhcccc
Q psy11022 250 NMYSYIMFIVLWIPFCIVMSVASFRHQ------ITPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCC 318 (492)
Q Consensus 250 ~~~~~~~f~i~~~P~~i~~~~~~~~~~------~~~~~~~~~~l~~~~s~~nP~IY~~~~~~~R~~~~~~~~~~~ 318 (492)
++++++.|.+||+|+.+..++....+. ...++....||++.|++.||+||++.|++||..+++.|++|.
T Consensus 263 liiVV~~FaicWlPyh~y~il~~~~~~i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf~~~fr~cp 337 (423)
T KOG4219|consen 263 LIIVVVIFAICWLPYHIYFILNATNPEINRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGFRRAFRWCP 337 (423)
T ss_pred HHHHHHHHHHhccChhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHHhhhhheee
Confidence 999999999999999999998876332 334445567999999999999999999999999999998664
|
|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4219|consensus | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes | Back alignment and domain information |
|---|
| >KOG4193|consensus | Back alignment and domain information |
|---|
| >PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4564|consensus | Back alignment and domain information |
|---|
| >PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity | Back alignment and domain information |
|---|
| >PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03125 Sre: C | Back alignment and domain information |
|---|
| >PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] | Back alignment and domain information |
|---|
| >PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans | Back alignment and domain information |
|---|
| >PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 492 | ||||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 1e-10 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 1e-10 | ||
| 2x72_A | 349 | Crystal Structure Of The Constitutively Active E113 | 5e-08 | ||
| 3oax_A | 349 | Crystal Structure Of Bovine Rhodopsin With Beta-Ion | 8e-08 | ||
| 1jfp_A | 348 | Structure Of Bovine Rhodopsin (Dark Adapted) Length | 8e-08 | ||
| 4a4m_A | 349 | Crystal Structure Of The Light-Activated Constituti | 1e-07 | ||
| 2j4y_A | 349 | Crystal Structure Of A Rhodopsin Stabilizing Mutant | 1e-07 | ||
| 3c9m_A | 348 | Structure Of A Mutant Bovine Rhodopsin In Hexagonal | 1e-07 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 7e-06 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 2e-05 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 3e-04 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 5e-05 | ||
| 4djh_A | 480 | Structure Of The Human Kappa Opioid Receptor In Com | 3e-04 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 3e-04 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 4e-04 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 5e-04 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 5e-04 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 5e-04 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 5e-04 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 7e-04 |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
|
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 | Back alignment and structure |
| >pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 | Back alignment and structure |
| >pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 | Back alignment and structure |
| >pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 | Back alignment and structure |
| >pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 | Back alignment and structure |
| >pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 | Back alignment and structure |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 492 | |||
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 4e-27 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 1e-07 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 9e-26 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 2e-06 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 1e-22 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 5e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-22 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 5e-06 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 3e-21 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 1e-04 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 6e-20 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 4e-16 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 7e-07 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 2e-06 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 5e-15 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 8e-07 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 9e-06 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 7e-15 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 3e-06 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 3e-05 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 1e-14 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 2e-06 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 3e-05 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 2e-14 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 2e-07 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 2e-05 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 8e-14 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 2e-06 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 9e-05 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 4e-12 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 1e-06 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 2e-04 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-11 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 5e-08 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 |
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 63/374 (16%), Positives = 136/374 (36%), Gaps = 47/374 (12%)
Query: 3 TPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMI 62
S + P + + + T D W V ++ + + + GN +I
Sbjct: 146 NLAKSRWYNQTPNRAKRVITTFRTGTWDAYAADEVW-VVGMGIVMSLIVLAIVFGNVLVI 204
Query: 63 SSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFL 122
+++ + L+ N +I A ADL++ V+P A IL C +
Sbjct: 205 TAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILTKT---WTFGNFWCEFWTSI 261
Query: 123 TLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYK 182
+LC ++ TL +IA++ Y + P + + +K+ + ++M+W+VS L + L
Sbjct: 262 DVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMH 321
Query: 183 VGPDYCSKKVS----------YMELYQGIIGSLF-FFIPIIITCILYMKITYKV--RLAR 229
+ ++ + I S+ F++P++I +Y ++ ++ R +
Sbjct: 322 WYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRV-FQEAKRQLQ 380
Query: 230 QNPSFKPPVIFGWDYSLMLTNMYSYIM-----------------------FIVLWIPFCI 266
+ + + + + F + W+PF I
Sbjct: 381 KIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFI 440
Query: 267 VMSVASFRHQITPS--FYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVT 324
V V + + + L W+ S N ++YC + FR A+ L C + +
Sbjct: 441 VNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYC-RSPDFRIAFQELL---CLRRSSL 496
Query: 325 FSRRSRGDATRPSG 338
+ + + +G
Sbjct: 497 KAYGNGYSSNGNTG 510
|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 492 | |||
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 100.0 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 100.0 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 100.0 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 100.0 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 100.0 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 100.0 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 100.0 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 100.0 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 100.0 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 100.0 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 100.0 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 100.0 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 100.0 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 100.0 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 100.0 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 100.0 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 100.0 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 100.0 | |
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 99.68 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 99.63 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 99.63 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 99.62 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 99.61 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 99.6 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 99.59 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 99.59 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 99.59 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 99.58 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 99.57 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 99.57 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 99.56 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 99.56 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 99.56 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 99.55 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 99.54 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 99.53 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.57 | |
| 2koe_A | 40 | Human cannabinoid receptor 1 - helix 7/8 peptide; | 98.45 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.37 | |
| 2ki9_A | 33 | Cannabinoid receptor 2; GPCR, G-protein coupled re | 97.31 | |
| 2lot_A | 64 | Apelin receptor; membrane protein; NMR {Homo sapie | 94.73 |
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=372.76 Aligned_cols=282 Identities=21% Similarity=0.292 Sum_probs=221.7
Q ss_pred CcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccc---cchhhHHHHHHHHHHHhhhchhcHHHHHHHhcCCCcccc
Q psy11022 35 PYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLR---RRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAEPI 111 (492)
Q Consensus 35 ~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr---~~~~~~l~~Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~ 111 (492)
.+.+..++..+++.+++++|++||+++++++.++|++| +++|+|++|||++|++.+++.+|+.+....... ..|.+
T Consensus 27 ~~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~-~~w~~ 105 (510)
T 4grv_A 27 TDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVH-HPWAF 105 (510)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC-SSCSS
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC-CCEEh
Confidence 34566788889999999999999999999998877655 678999999999999999899999887655432 25999
Q ss_pred ccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHHhHhhHHHHHHHHHhhhhhhhcc--------
Q psy11022 112 KEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWLVSILLTTLQFIYKV-------- 183 (492)
Q Consensus 112 ~~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~-------- 183 (492)
|+.+|++..++...+..+|++++++||+|||+||++|++|+..++++++..+++++|++++++++|+++...
T Consensus 106 g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~ 185 (510)
T 4grv_A 106 GDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADG 185 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSS
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999886421
Q ss_pred ---ccccccccccc--chhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcC---------------------------
Q psy11022 184 ---GPDYCSKKVSY--MELYQGIIGSLFFFIPIIITCILYMKITYKVRLARQN--------------------------- 231 (492)
Q Consensus 184 ---~~~~C~~~~~~--~~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~~~--------------------------- 231 (492)
....|...++. ...+..+..++.+++|+++++++|.+|+++++++.+.
T Consensus 186 ~~~~~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (510)
T 4grv_A 186 THPGGLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIG 265 (510)
T ss_dssp CCGGGEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEEEETT
T ss_pred CCCCccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccccccc
Confidence 11235544432 3455666667889999999999999999999753210
Q ss_pred --------------------------------------------------------------------------------
Q psy11022 232 -------------------------------------------------------------------------------- 231 (492)
Q Consensus 232 -------------------------------------------------------------------------------- 231 (492)
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 345 (510)
T 4grv_A 266 HLLTKSPSLNAAKSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETG 345 (510)
T ss_dssp EECCCSSSHHHHHHSCCC---CCCTTBCCHHHHHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCCCccccccCcCCCCCCCCcccCCccccccCCCCcccccccccCCCCCCCcCccccccccccCCccccCCCCC
Confidence
Q ss_pred -----------------------------------------------CCCCCCcccchhhHHHHHHHHHHHHHHHHhHhH
Q psy11022 232 -----------------------------------------------PSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPF 264 (492)
Q Consensus 232 -----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~P~ 264 (492)
.+.+..+..++|+|++|++++++++|++||+|+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iCWlPf 425 (510)
T 4grv_A 346 VAGFTNSLRMLNNKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVCWLPY 425 (510)
T ss_dssp HTTCHHHHHHHTTTCHHHHHHHHHSSCSCCSSHHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCccccccccCCCcccccccccccccccCCccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 000111223567899999999999999999999
Q ss_pred HHHHHHHhccCCc----------chHHHHHHHHHhhcccccchhhhhcChHHHHHHHHHhccc
Q psy11022 265 CIVMSVASFRHQI----------TPSFYYLAWLALSKSCINSVLYCISNRHFRNAYINLFHYC 317 (492)
Q Consensus 265 ~i~~~~~~~~~~~----------~~~~~~~~~l~~~~s~~nP~IY~~~~~~~R~~~~~~~~~~ 317 (492)
.+..++..+.+.. .....+..||.|+||++||+||+++|++||++++++++++
T Consensus 426 ~i~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~L~Y~NS~iNPiIY~~~n~~FR~aFk~iL~C~ 488 (510)
T 4grv_A 426 HVRRLMFCYISDEQWTTFLFDFYHYFYMLTNALAYASSAINPILYNLVSANFRQVFLSTLACL 488 (510)
T ss_dssp HHHHHHHHTTTTTCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCC--------
T ss_pred HHHHHHHHHcCcccCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHhhc
Confidence 9999887762211 1234456789999999999999999999999999999643
|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} | Back alignment and structure |
|---|
| >2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 492 | ||||
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 9e-13 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.3 bits (163), Expect = 9e-13
Identities = 49/292 (16%), Positives = 95/292 (32%), Gaps = 14/292 (4%)
Query: 50 LSVLGSVGNGYMISSVMIEDHLRRRGNTYIAVEALADLLVSGVVIPVSAVMILAGIKQAE 109
L +LG N + + LR N + A+ADL + + L G
Sbjct: 47 LIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYFVFG 106
Query: 110 PIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHIILSVIMIWL 169
P + L +L ++ LA+ + + + + +M
Sbjct: 107 PTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALA 166
Query: 170 VSILLTTLQFIYKVGPDYCSKKVSYM--------ELYQGIIGSLFFFIPIIITCILYMKI 221
+ Y CS + Y E + + + F IP+I+ Y ++
Sbjct: 167 CAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQL 226
Query: 222 TYKVRLARQNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASFRHQITPSF 281
+ V+ A + + + + I F++ W+P+ V
Sbjct: 227 VFTVKEAAAQQ-QESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGP 285
Query: 282 YYL---AWLALSKSCINSVLYCISNRHFRNAYINLFHYCCCKTTVTFSRRSR 330
++ A+ A + + N V+Y + N+ FRN + CC K + S
Sbjct: 286 IFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTL--CCGKNPLGDDEAST 335
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 492 | |||
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 99.28 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.2e-38 Score=303.71 Aligned_cols=307 Identities=18% Similarity=0.234 Sum_probs=238.5
Q ss_pred CCCCCCCccccccccccCCCCCCCCCCCCCCCCCcchHHHHHHHHHHHHHHHHhhhcceeeeeeeeccccccchhhHHHH
Q psy11022 2 MTPDFSSNNSLFPFTTELLTSATPMDTVDPSTLPYDWNRVARLLITTGLSVLGSVGNGYMISSVMIEDHLRRRGNTYIAV 81 (492)
Q Consensus 2 m~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~gl~gN~~vi~~i~~~~~lr~~~~~~l~~ 81 (492)
|+++++.+..++..+.+... ....+.......+++...+.+.++.+++++|++||+++++++.++|++|++.|++++|
T Consensus 1 ~~~~~~~~~~~~~~n~t~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~n 78 (348)
T d1u19a_ 1 MNGTEGPNFYVPFSNKTGVV--RSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLN 78 (348)
T ss_dssp CCSEECSSCEESSCCTTSCC--CCTTTSCCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHH
T ss_pred CCCCCCCCccccCCCCCCCc--CCCCCCCccccccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHH
Confidence 55555666554333322222 2222223334455666778889999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhchhcHHHHHHHhcCCCccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCcccccccchhhHH
Q psy11022 82 EALADLLVSGVVIPVSAVMILAGIKQAEPIKEIMCHVQWFLTLLCSLVTVWTLAMIAMENYVRLCMPPECYTFFSKSHII 161 (492)
Q Consensus 82 Lai~Dll~~~~~~p~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~ia~dRy~aI~~P~~~~~~~t~~~~~ 161 (492)
||++|++.++...|..+.....+. |..++..|+...+....+..++.++++++++|||++|++|++|... ++++..
T Consensus 79 LaiaDll~~~~~~~~~~~~~~~~~---~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~-~~~~~~ 154 (348)
T d1u19a_ 79 LAVADLFMVFGGFTTTLYTSLHGY---FVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRF-GENHAI 154 (348)
T ss_dssp HHHHHHHHHHHTHHHHHHHHHHTS---CTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCC-CHHHHH
T ss_pred HHHHHHHHHHHHHHHhhhhhccCc---cccCchhhhhhhhccccceeeecchhhhhhcccceeeecccccccc-cccccc
Confidence 999999999888998887776663 6788899999999999999999999999999999999999887664 666777
Q ss_pred hHhhHHHHHHHHHhhhhhhhcc------cccccccc------cccchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q psy11022 162 LSVIMIWLVSILLTTLQFIYKV------GPDYCSKK------VSYMELYQGIIGSLFFFIPIIITCILYMKITYKVRLAR 229 (492)
Q Consensus 162 ~~i~~~w~~s~~~~~~~~~~~~------~~~~C~~~------~~~~~~~~~~~~~~~~~ip~~ii~~~y~~i~~~l~~~~ 229 (492)
..++.+|..++++..++..... ....|... ......+......+..++|++++.++|.++.+++||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~ 234 (348)
T d1u19a_ 155 MGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAA 234 (348)
T ss_dssp HHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEEECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCC
T ss_pred ccceeeehhhhheecccccccceeccCCcccccccccccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhcccc
Confidence 7778888888888877765421 12223322 12234455666667789999999999999988887765
Q ss_pred cCCCCCCCcccchhhHHHHHHHHHHHHHHHHhHhHHHHHHHHhc---cCCcchHHHHHHHHHhhcccccchhhhhcChHH
Q psy11022 230 QNPSFKPPVIFGWDYSLMLTNMYSYIMFIVLWIPFCIVMSVASF---RHQITPSFYYLAWLALSKSCINSVLYCISNRHF 306 (492)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~P~~i~~~~~~~---~~~~~~~~~~~~~l~~~~s~~nP~IY~~~~~~~ 306 (492)
++ +++..++.++|+|.+|+++.++++|++||+|+.+..++... .+.......+..++.++|+++||+||+++|++|
T Consensus 235 ~~-~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~f 313 (348)
T d1u19a_ 235 AQ-QQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQF 313 (348)
T ss_dssp CS-SCSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHH
T ss_pred cc-cchhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHH
Confidence 43 33444556778999999999999999999999988876655 223344566677889999999999999999999
Q ss_pred HHHHHHHhc
Q psy11022 307 RNAYINLFH 315 (492)
Q Consensus 307 R~~~~~~~~ 315 (492)
|++++++++
T Consensus 314 R~~~~~~l~ 322 (348)
T d1u19a_ 314 RNCMVTTLC 322 (348)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHhC
Confidence 999999984
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|